98 related articles for article (PubMed ID: 17667593)
1. Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells.
Puglisi F; Andreetta C; Valent F; Minisini AM; Rijavec E; Russo S; Mansutti M; Cardellino G; Pizzolitto S; Di Loreto C
Anticancer Drugs; 2007 Sep; 18(8):883-8. PubMed ID: 17667593
[TBL] [Abstract][Full Text] [Related]
2. Reproducible immunohistochemical criteria based on multiple raters' judgments for expression of thymidine phosphorylase in breast cancer tissue.
Tsuda H; Akiyama F; Kurosumi M; Sakamoto G
Breast Cancer Res Treat; 2004 Aug; 86(3):215-23. PubMed ID: 15567938
[TBL] [Abstract][Full Text] [Related]
3. Significance of thymidine phosphorylase expression in stromal cells around invasive front of rectal cancer.
Kobayashi T; Kawahara H; Koido S; Kobayashi S; Kashiwagi H; Yanaga K
Hepatogastroenterology; 2008; 55(88):2045-8. PubMed ID: 19260474
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.
Kurosumi M; Sugamata N; Tabei T; Inoue K; Matsumoto H; Suemasu K; Higashi Y
Anticancer Res; 2002; 22(1A):331-8. PubMed ID: 12017313
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of thymidine phosphorylase in gastric cancer: is there a role of the differential expression in tumor cells and associated stromal cells?
Liakakos T; Troupis T; Ghiconti I; Triantafyllidis S; Macheras A; Karatzas G; Pavlakis K
Anticancer Res; 2006; 26(5B):3899-903. PubMed ID: 17094420
[TBL] [Abstract][Full Text] [Related]
6. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
7. Renal tubular dysfunction and urinary zinc excretion in breast cancer patients treated with anthracycline-based combination chemotherapy.
Králícková P; Melichar B; Malír F; Roubal T
J Exp Clin Cancer Res; 2004 Dec; 23(4):579-84. PubMed ID: 15743027
[TBL] [Abstract][Full Text] [Related]
8. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
Kim TD; Li G; Song KS; Kim JM; Kim JS; Kim JS; Yun EJ; Park JI; Park HD; Hwang BD; Lim K; Yoon WH
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):853-60. PubMed ID: 19215821
[TBL] [Abstract][Full Text] [Related]
10. Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
Rocca A; Viale G; Gelber RD; Bottiglieri L; Gelber S; Pruneri G; Ghisini R; Balduzzi A; Pietri E; D'Alessandro C; Goldhirsch A; Colleoni M
Cancer Chemother Pharmacol; 2008 May; 61(6):965-71. PubMed ID: 17639392
[TBL] [Abstract][Full Text] [Related]
11. Biological markers as predictive factors of response to neoadjuvant taxanes and anthracycline chemotherapy in breast carcinoma.
Zhou B; Yang DQ; Xie F
Chin Med J (Engl); 2008 Mar; 121(5):387-91. PubMed ID: 18364105
[TBL] [Abstract][Full Text] [Related]
12. [Activity of the enzymes of DNA metabolism in the blood of patients with breast cancer].
Borzenko BG; Gorbachev AA; Dumanskiĭ IuV; Shevchenko VV; Shepliakov MN
Vopr Onkol; 1990; 36(1):17-23. PubMed ID: 2154896
[TBL] [Abstract][Full Text] [Related]
13. Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.
Bartsch R; Steger GG; Forstner B; Wenzel C; Pluschnig U; Rizovski B; Altorjai G; Zielinski CC; Mader RM
BMC Clin Pharmacol; 2007 Jul; 7():7. PubMed ID: 17640356
[TBL] [Abstract][Full Text] [Related]
14. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
Tang SC
Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
[TBL] [Abstract][Full Text] [Related]
15. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
[TBL] [Abstract][Full Text] [Related]
16. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
18. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
19. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
20. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
